Your browser doesn't support javascript.
loading
SARS-CoV2/COVID-19 Infection in Transplant Recipients and in Patients on the Organ Transplant Waiting List in Colombia.
Arias-Murillo, Yazmin R; Benavides-V, Carlos A; Salinas-N, María A; Osorio-Arango, Karime; Plazas-Sierra, Carolina; Cortés, Jorge A.
Afiliación
  • Arias-Murillo YR; Coordination of the National Donation and Transplant Network, Blood Bank, Transfusion, and Transplant Research Group, Direction of Public Health Networks, Instituto Nacional de Salud, Bogotá, Colombia. Electronic address: yarias@ins.gov.co.
  • Benavides-V CA; Fundación Cardioinfantil, Transplant Surgeon, Bogotá, Colombia.
  • Salinas-N MA; Coordination of the National Donation and Transplant Network, Blood Bank, Transfusion, and Transplant Research Group, Direction of Public Health Networks, Instituto Nacional de Salud, Bogotá, Colombia.
  • Osorio-Arango K; Instituto de Evaluación Tecnológica en Salud (IETS), Bogotá, Colombia.
  • Plazas-Sierra C; Coordination of the National Donation and Transplant Network, Blood Bank, Transfusion, and Transplant Research Group, Direction of Public Health Networks, Instituto Nacional de Salud, Bogotá, Colombia.
  • Cortés JA; Department of Internal Medicine and Infectious Diseases Research Group, School of Medicine, Universidad Nacional de Colombia, National University Hospital of Colombia, Bogotá, Columbia.
Transplant Proc ; 53(4): 1237-1244, 2021 May.
Article en En | MEDLINE | ID: mdl-33558085
To assess our determination to continue transplant activity in Colombia during the coronavirus disease 2019 (COVID-19) pandemic, this study seeks to describe the risk of infection and mortality of transplanted patients vs those on the waiting list. Therefore, a descriptive study of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)/COVID-19 infection in transplant recipients and patients on the waiting list was conducted. The data sources were the information systems of the Instituto Nacional de Salud of Colombia: National Donation and Transplant Information System, the National Public Health Surveillance System, and the National COVID-19 Data Repository. Characteristics of the patients who tested positive were analyzed, and the mortality rate was determined. An Real Time-PCR test for SARS-CoV-2/COVID-19 was performed in 7% of the transplant recipients included in this study, and 14.8% of those recipients tested positive. Among patients on the waiting list, 15.2% were tested, and 16.7% showed positive results. Overall, 1% (84/8108) of the transplant recipients and 2.5% (74/2926) of patients on the waiting list were infected with SARS-CoV-2/COVID-19. There were no differences in mortality between these groups (P = .8748). In conclusion, with the data obtained so far, the hospital availability, and the adoption of safety protocols in the institutions, our findings can support the continuity of the transplant activities in this country.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Órganos / COVID-19 Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do sul / Colombia Idioma: En Revista: Transplant Proc Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Órganos / COVID-19 Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do sul / Colombia Idioma: En Revista: Transplant Proc Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos